Hormone Therapy and Bone Health: A Naturopathic Guide

If you’re approaching menopause, you’ve probably heard your bones are at risk — but you may not know exactly why, or what to do about it. The relationship between hormone therapy and bone health is one of the most well-studied areas in menopause medicine, and understanding it can help you make an informed, personalized decision about your care. At Aya Naturopathic Medicine, we look at hormone therapy and bone health together, because protecting your skeleton during this transition takes more than a single prescription — it takes a whole-body strategy.

Why Hormones Matter for Your Bones

Bone isn’t static. It’s living tissue that’s constantly being broken down and rebuilt in a process called remodeling. Estrogen plays a central role in keeping this cycle balanced by slowing down the cells that break down bone (osteoclasts) while supporting the cells that build it back up (osteoblasts) (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS], 2023).

When estrogen levels drop sharply during perimenopause and menopause, bone breakdown starts to outpace bone formation. This is why women can lose up to 20% of their bone density in the five to seven years following menopause (NIAMS, 2023). Testosterone, though present in much smaller amounts in women, also contributes to bone strength — which is one reason hormone balance, not just estrogen alone, matters when we talk about hormone therapy and bone health.

How Hormone Therapy and Bone Health Are Connected

Hormone replacement therapy (HRT) — sometimes called menopausal hormone therapy (MHT) — was one of the first treatments shown to meaningfully reduce fracture risk in postmenopausal women. The Women’s Health Initiative, one of the largest studies on this topic, found that combined estrogen-progestin therapy reduced hip fractures by 33% and total fractures by 24% compared to placebo (Rossouw et al., 2002). More recent guidance from The Menopause Society continues to recognize hormone therapy as an effective, first-line option for preventing bone loss in women who start it within 10 years of menopause onset or before age 60 (The Menopause Society, 2022).

In practical terms, this is what makes the link between hormone therapy and bone health so significant: by restoring estrogen levels, HRT directly slows the rate of bone resorption, helping preserve bone mineral density (BMD) at the hip and spine — the two sites most vulnerable to osteoporotic fracture.

Types of Hormone Therapy to Discuss With Your Provider

Not all hormone therapy looks the same, and the right choice depends on your health history, symptoms, and goals:

• Systemic estrogen therapy (pills, patches, or gels) — supports bone density body-wide and is typically recommended for women with moderate to severe menopause symptoms alongside bone health goals.
• Combined estrogen-progestin therapy — used for women who still have a uterus, to protect the uterine lining while supporting bone.
• Bioidentical hormone therapy — compounded or FDA-approved formulations structurally identical to the hormones your body produces, which some patients prefer for a more individualized approach.
• Low-dose or localized options — may address symptoms like vaginal dryness but generally provide less protective effect on bone density than systemic therapy.

This is exactly the kind of decision where a personalized consultation matters — what supports hormone therapy and bone health for one patient may not be right for another. Book a consultation with our team to review your options in detail.

A Naturopathic, Whole-Body Approach

Hormone therapy is a powerful tool, but at Aya Naturopathic Medicine, we don’t view it in isolation. A comprehensive strategy for hormone therapy and bone health includes:

• Nutrient support: Calcium (1,000–1,200 mg/day) and vitamin D (1,000–2,000 IU/day) remain foundational for bone mineralization (NIAMS, 2023). Magnesium and vitamin K2 also play supporting roles in how calcium is deposited into bone rather than soft tissue.
• Weight-bearing exercise: Activities like walking, resistance training, and dancing stimulate osteoblast activity and can meaningfully slow bone loss.
• Blood sugar and inflammation management: Chronic inflammation and insulin resistance are increasingly linked to accelerated bone turnover, making dietary strategy an important complement to hormone therapy.
• Bone density monitoring: A baseline DEXA scan, repeated every one to two years, helps track how well your combined approach — hormonal and lifestyle — is working.
• Bone turnover lab testing: As naturopathic doctors, we can also order specialized bone turnover markers that give a more real-time picture than a DEXA scan alone. CTX (C-terminal telopeptide) reflects the rate of bone breakdown, while P1NP (procollagen type 1 N-terminal propeptide) reflects the rate of new bone formation (Vasikaran et al., 2011). Tracking these markers a few months after starting hormone therapy — or after adjusting nutrition and exercise — can show whether your bone remodeling is shifting in the right direction well before your next DEXA scan is due. We often pair these with vitamin D, magnesium, and full hormone panels to build a complete picture of what’s driving your bone health.

You can read more about our approach to menopause support and personalized nutrition on our website.

Risks and Considerations

Hormone therapy isn’t right for everyone, and the conversation around hormone therapy and bone health has to include the risks. Systemic estrogen therapy carries a small increased risk of blood clots, stroke, and — depending on the formulation and duration of use — breast cancer, particularly with combined estrogen-progestin regimens started more than 10 years after menopause (The Menopause Society, 2022). Women with a history of hormone-sensitive cancers, unexplained vaginal bleeding, active liver disease, or clotting disorders typically need alternative strategies for bone protection.

This is why we always recommend a thorough individual risk assessment before starting therapy — ideally with a provider who can weigh your full health picture, not just your bone density score.

When to Talk to a Provider

If you’re in perimenopause or menopause and concerned about your bone health, don’t wait for a fracture to start the conversation. Signs it’s time to talk to a provider include:

• A family history of osteoporosis or hip fracture
• Early menopause (before age 45) or surgical menopause
• A DEXA scan showing osteopenia or osteoporosis
• Persistent menopause symptoms alongside bone health concerns

The Bottom Line

The evidence connecting hormone therapy and bone health is strong: for many women, starting therapy near the onset of menopause offers real protection against fracture, alongside relief from other menopause symptoms. But the best outcomes come from combining hormone therapy with nutrition, movement, and ongoing monitoring — a truly naturopathic, whole-person approach.

Ready to build a personalized plan for your bone health? Schedule a consultation with Dr. Luciana Silva and the Aya Naturopathic Medicine team to discuss whether hormone therapy is right for you.

References

National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2023). Osteoporosis: Peak bone mass in women. U.S. Department of Health and Human Services. https://www.niams.nih.gov/health-topics/osteoporosis

Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., & Ockene, J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333. https://doi.org/10.1001/jama.288.3.321

The Menopause Society. (2022). The 2022 hormone therapy position statement of The Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028

Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., Trenti, T., Wahl, D. A., Cooper, C., & Kanis, J. A. (2011). Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporosis International, 22(2), 391–420. https://doi.org/10.1007/s00198-010-1501-1